SOX2 and esophageal squamous cell carcinoma: To further validate CD44+/CD24− as a putative CSC population in EC, we studied the protein expression of the pluripotent stem cell marker SOX2 in OE33 and OE21 cells, which derived from EAC and ESCC, respectively.